Mind the gap! Addressing unresolved aspects of abuse potential evaluation and scheduling of classic and novel psychedelic drugs.

Psychedelic research is progressing at breakneck speed and is creating new challenges for drug developers, regulatory authorities, and legislators. Most "classic" psychedelics undergoing clinical investigation are C-I controlled drugs with perceived…

Preview only. Read the full abstract at the source